{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-22-002578","form_type":"8-K/A","ticker":"YBGJ","cik":"0000895464","company_name":"Yubo International Biotech Ltd","filed_at":"2022-12-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.920747+00:00","generated_at":"2026-06-21T08:30:05.053346+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Yubo International amends share agreement to settle $819,229 in loans with World Precision Medicine","bullets":["Gross proceeds of $819,229 from 1,638,458 shares at $0.50 will settle all outstanding loan principal and accrued interest.","Upon delivery, Company has no further repayment obligations and any liens are automatically released.","Amendment is retroactive to September 2, 2022, executed December 6, 2022, clarifying use of proceeds.","Shares issued in a registered direct offering under effective S-1 registration statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-22-002578","json":"https://secwatch.observer/filing/0001640334-22-002578.json","markdown":"https://secwatch.observer/filing/0001640334-22-002578.md","text":"https://secwatch.observer/filing/0001640334-22-002578.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/895464/000164033422002578/0001640334-22-002578-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/895464/000164033422002578/yubo_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T08:30:05.053346+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4de7dceaa32ebdb8a93a1dfe5fdef053a7ae488b","claim":"Yubo International Biotech Ltd entered into Securities Purchase Agreement with World Precision Medicine Technology Limited valued at $819,229 (effective 2022-09-02).","evidence_excerpt":"On September 2, 2022, Yubo International Biotech Limited, a New York Corporation (the “ Company ”) entered into a Securities Purchase Agreement with World Precision Medicine Technology Limited (the “ Purchaser ”), as further amended by an Amendment to Securities Purchase Agreement, effective as of September 2, 2022, by and between the Company and the Purchaser (as amended, the “ Securities Purchase Agreement ”), pursuant to which the Company agreed to sell and issue to the Purchaser an aggregate of 1,638,458 shares (the “ Shares ”) of Class A Common Stock, par value $0.001 per share, of the Company, at $0.50 per share, for gross proceeds of $819,229.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/895464/000164033422002578/0001640334-22-002578-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"World Precision Medicine Technology Limited"},{"label":"Value","value":"$819,229"},{"label":"Effective","value":"2022-09-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}